Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenerative Medical Technology (RMTG) Invested Capital (2017 - 2025)

Historic Invested Capital for Regenerative Medical Technology (RMTG) over the last 9 years, with Q3 2025 value amounting to -$30.0 million.

  • Regenerative Medical Technology's Invested Capital fell 1245.93% to -$30.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.0 million, marking a year-over-year decrease of 1245.93%. This contributed to the annual value of -$27.4 million for FY2024, which is 2550.61% down from last year.
  • Latest data reveals that Regenerative Medical Technology reported Invested Capital of -$30.0 million as of Q3 2025, which was down 1245.93% from -$29.0 million recorded in Q2 2025.
  • Regenerative Medical Technology's 5-year Invested Capital high stood at $4.2 million for Q2 2021, and its period low was -$30.0 million during Q3 2025.
  • Over the past 5 years, Regenerative Medical Technology's median Invested Capital value was -$15.7 million (recorded in 2023), while the average stood at -$16.7 million.
  • Its Invested Capital has fluctuated over the past 5 years, first surged by 22159.6% in 2021, then crashed by 32909.77% in 2022.
  • Quarter analysis of 5 years shows Regenerative Medical Technology's Invested Capital stood at -$6.8 million in 2021, then crashed by 77.33% to -$12.0 million in 2022, then plummeted by 81.88% to -$21.8 million in 2023, then fell by 25.51% to -$27.4 million in 2024, then decreased by 9.85% to -$30.0 million in 2025.
  • Its Invested Capital stands at -$30.0 million for Q3 2025, versus -$29.0 million for Q2 2025 and -$28.1 million for Q1 2025.